|
Report Date : |
18.04.2014 |
IDENTIFICATION DETAILS
|
Name : |
PHARMACEUTICAL ENTERPRISES BELGIUM NV |
|
|
|
|
Registered Office : |
Molenberglei 20 2627 Schelle |
|
|
|
|
Country : |
Belgium |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
25.04.1995 |
|
|
|
|
Com. Reg. No.: |
455014924 |
|
|
|
|
Legal Form : |
Public
Limited Liability Company (BE) |
|
|
|
|
Line of Business : |
Wholesale
of pharmaceutical goods |
|
|
|
|
No. of Employees |
1 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
Moderate |
|
Payment Behaviour : |
Slow |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2014
|
Country Name |
Previous Rating (30.09.2013) |
Current Rating (01.12.2013) |
|
Belgium |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BELGIUM - ECONOMIC OVERVIEW
This modern, open, and private-enterprise-based economy has capitalized
on its central geographic location, highly developed transport network, and
diversified industrial and commercial base. Industry is concentrated mainly in
the more heavily-populated region of Flanders in the north. With few natural
resources, Belgium imports substantial quantities of raw materials and exports
a large volume of manufactures, making its economy vulnerable to volatility in
world markets. Roughly three-quarters of Belgium's trade is with other EU
countries, and Belgium has benefited most from its proximity to Germany. In
2013 Belgian GDP grew by 0.1%, the unemployment rate increased to 8.8% from
7.6% the previous year, and the government reduced the budget deficit from a
peak of 6% of GDP in 2009 to 3.2%. Despite the relative improvement in
Belgium's budget deficit, public debt hovers around 100% of GDP, a factor that
has contributed to investor perceptions that the country is increasingly
vulnerable to spillover from the euro-zone crisis. Belgian banks were severely
affected by the international financial crisis in 2008 with three major banks
receiving capital injections from the government, and the nationalization of
the Belgian retail arm of a Franco-Belgian bank.
|
Source
: CIA |
Business number 455014924
Company name PHARMACEUTICAL
ENTERPRISES BELGIUM NV
Address MOLENBERGLEI 20
2627 SCHELLE
Number of staff 1
Date of establishment 25/04/1995
Telephone number 038808770
Fax number 038441648
|
The business
was established over 18 years ago. |
|
|
The
business has 1 employees. |
|
|
The
business has been at the address for over 18 years. |
|
|
There has
been no significant change in the business's credit limit. |
|
|
The credit
rating for this business has decreased from 53 to 34. |
|
|
Operating
Result in the latest trading period increased 955% on the previous trading
period. |
|
|
A 22%
growth in Total Assets occurred during the latest trading period. |
|
|
The business
saw an increase in their Cash Balance of 411% during the latest trading
period. |
|
|
Net Worth
is a negative amount during the latest trading period. |
|
|
Working
Capital is a negative amount during the latest trading period. |
|
|
Accounts |
||||
|
DATE OF LATEST
ACCOUNTS |
TURNOVER |
PROFIT BEFORE TAX |
NET WORTH |
WORKING CAPITAL |
|
31/12/2012 |
|
-8,203 |
-957,642 |
-140,892 |
|
31/12/2011 |
|
-80,510 |
-951,124 |
-38,647 |
|
31/12/2010 |
|
7,698 |
-881,171 |
42,684 |
|
Accounts |
||||
|
DATE OF LATEST
ACCOUNTS |
BALANCE TOTAL |
NUMBER OF EMPLOYEES |
CAPITAL |
CASHFLOW |
|
31/12/2012 |
1,348,442 |
1 |
332,772 |
771 |
|
31/12/2011 |
1,097,970 |
2 |
332,772 |
-66,965 |
|
31/12/2010 |
539,922 |
2 |
332,772 |
16,767 |
|
Past
payments |
|
Payment
expectation days |
- |
|
Industry average payment expectation days |
75.44 |
Industry average day sales outstanding |
115.08 |
|
Day
sales outstanding |
- |
||
|
Court
data summary |
|||
|
BANKRUPTCY
DETAILS |
|||
|
Court
action type |
no |
||
PROTESTED BILLS
Bill
amount –
NSSO DETAILS
Date
of summons 29/03/2043
|
Business
number |
455014924 |
Company
name |
PHARMACEUTICAL
ENTERPRISES BELGIUM NV |
|
Fax
number |
038441648 |
Date
founded |
25/04/1995 |
|
Company
status |
active |
Company
type |
Public Limited
Liability Company (BE) |
|
Currency |
Euro
(€) |
Date
of latest accounts |
31/12/2012 |
|
Activity
code |
46460 |
liable
for VAT |
yes |
|
Activity
description |
Wholesale
of pharmaceutical goods |
VAT
Number |
BE.0455.014.924 |
|
Belgian
Bullettin of Acts Publications |
moniteur
belge |
|
|
|
Contractor
details |
|
|
Check Article 30 Bis |
|
Registered contractor number |
- |
|
|
|
Contractor
description |
- |
||
|
Date
struck off register |
|
||
|
Social
Balance Sheet |
Total |
|||
|
During the reporting year ended 31-12-2012 |
|
|||
|
Full-time
Employees |
2 |
|||
|
Part-time
Employees |
1 |
|||
|
Total
Fte Employees |
2 |
|||
|
|
|
|||
|
Number
of hours worked |
|
|||
|
Full-time
Employees |
1,622 |
|||
|
Part-time
Employees |
866 |
|||
|
Total |
2,488 |
|||
|
|
|
|||
|
Personnel
Charges |
|
|||
|
Full-time
Employees |
60,882 |
|||
|
Part-time
Employees |
32,497 |
|||
|
Total |
93,380 |
|||
|
Benefits
In Addition To Wages |
- |
|||
|
|
|
|||
|
During
the previous reporting year |
|
|||
|
Average
number employees in Fte |
3 |
|||
|
Actual
working hours |
3,182 |
|||
|
Personnel
Charges |
123,886 |
|||
|
Benefits
In Addition To Wages |
- |
|||
|
Type
of Contract |
Full-Time |
Part-Time |
Total
Fte |
|
|
Unlimited Duration Contracts |
1 |
1 |
2 |
|
|
Limited
Duration Contracts |
- |
- |
- |
|
|
Contracts
For Specific Work |
- |
- |
- |
|
|
Contracts
Regarding Substitution |
- |
- |
- |
|
|
Gender and Education Level |
|
|||
|
Men |
Full-Time |
Part-Time |
Total
Fte |
|
|
Primary
education |
- |
- |
- |
|
|
Secondairy
education |
- |
- |
- |
|
|
Higher education (non university) |
- |
- |
- |
|
|
Higher education (university) |
- |
- |
- |
|
|
Women |
Full-Time |
Part-Time |
Total
Fte |
|
|
Primary
education |
- |
- |
- |
|
|
Secondairy
education |
1 |
1 |
2 |
|
|
Higher education (non university) |
- |
- |
- |
|
|
Higher
education (university) |
- |
- |
- |
|
|
|
||||
|
Working
Category |
Full-Time |
Part-Time |
Total
Fte |
|
|
Management |
- |
- |
- |
|
|
White
collar worker |
1 |
1 |
2 |
|
|
Blue
collar worker |
- |
- |
- |
|
|
Other |
- |
- |
- |
|
|
|
||||
|
Temporary
personnel |
Total |
|||
|
Average
number of temporary staff |
- |
|||
|
Actual
working hours |
- |
|||
|
Cost
of temporary staff |
- |
|||
|
|
||||
|
New
staff and leavers |
Full-Time |
Part-Time |
Total
Fte |
|
|
New
Starters |
- |
- |
- |
|
|
Leavers |
1 |
- |
1 |
|
|
Number
of employees |
- |
- |
|
|
|
Number
of training hours |
- |
- |
|
|
|
Net
costs for enterprise |
- |
- |
|
|
|
Total of less formal and informal continuing
vocational training initiatives for workers paid by the employer |
Male |
Female |
|
|
|
Number
of employees |
- |
- |
|
|
|
Number
of training hours |
- |
- |
|
|
|
Net
costs for enterprise |
- |
- |
|
|
|
Total of initial training initiatives at
the expense of the employer |
Male |
Female |
|
|
|
Number
of employees |
- |
- |
|
|
|
Number
of training hours |
- |
- |
|
|
|
Net
costs for enterprise |
- |
- |
|
|
Personnel (NSSO classification)
|
Code |
- |
|
Description |
FROM
1 TO 4 EMPLOYEES |
|
Joint
Industrial Committee (JIC) |
|
|
JIC
Code |
116 |
|
Description |
Joint
committee for the chemical industry |
|
category |
|
|
|
|
|
JIC
Code |
207 |
|
Description |
Joint
committee for the employees off he chemical industry |
|
category |
|
|
Significant
Events |
|
|
Event
Date |
17/06/2011 |
|
Event
Description |
re-appointment
of director(s) |
|
Event
Details |
Commentaar
17-06-2011: Herbenoemd als bestuurders voor een periode van zes jaar: Marc
Waeterschoot (tevens gedelegeerd bestuurder) en Patrick Swolfs. |
Profit & loss
|
|
Annual accounts |
31-122012 |
% |
31-122011 |
% |
31-122010 |
Industry average 2012 |
% |
|
|
Weeks |
52 |
|
52 |
|
52 |
|
|
|
|
Currency |
EUR |
|
EUR |
|
EUR |
|
|
|
Turnover |
- |
- |
- |
- |
- |
37,945,127 |
- |
|
|
|
Total operating expenses |
- |
- |
- |
- |
- |
37,723,402 |
- |
|
|
Operating result |
50,855 |
955 |
4,817 |
-94.04 |
80,831 |
134,193 |
-62.10 |
|
|
Total financial income |
32,809 |
85.92 |
17,647 |
23.49 |
14,291 |
782,494 |
-95.81 |
|
|
Total financial expenses |
91,867 |
-10.79 |
102,974 |
17.79 |
87,424 |
695,657 |
-86.79 |
|
|
Results on ordinary operations before taxation |
-8,203 |
10.19 |
-80,510 |
-1145 |
7,698 |
149,993 |
-105 |
|
|
Taxation |
- |
- |
- |
- |
- |
173,383 |
- |
|
|
Results on ordinary operations after taxation |
-8,203 |
10.19 |
-80,510 |
-1145 |
7,698 |
17,545 |
-146 |
|
|
Extraordinary items |
1,685 |
-84.04 |
10,557 |
79.03 |
5,897 |
-1,049 |
160 |
|
|
Other appropriations |
0.00 |
- |
0.00 |
- |
0.00 |
- |
- |
|
|
Net result |
-6,518 |
9.32 |
-69,954 |
-614 |
13,595 |
17,318 |
-137 |
|
OTHER INFORMATION |
||||||||
|
|
Dividends |
- |
- |
- |
- |
- |
1,415,985 |
- |
|
|
Director remuneration |
- |
- |
- |
- |
- |
270,927 |
- |
|
|
Employee costs |
93,380 |
-24.62 |
123,886 |
-19.84 |
154,543 |
2,665,389 |
-96.50 |
|
|
Wages and salary |
70,958 |
-25.89 |
95,740 |
-16.23 |
114,291 |
1,933,710 |
-96.33 |
|
|
Employee pension costs |
- |
- |
- |
- |
- |
267,189 |
- |
|
|
Social security
contributions |
18,920 |
-26.25 |
25,653 |
-15.36 |
30,307 |
527,954 |
-96.42 |
|
|
Other employee costs |
3,502 |
40.51 |
2,492 |
-74.94 |
9,946 |
155,569 |
-97.75 |
|
|
Amortization and depreciation |
7,288 |
143 |
2,988 |
-5.80 |
3,172 |
1,066,658 |
-99 |
balance sheet
|
|
Annual accounts |
31-122012 |
% |
31-122011 |
% |
31-122010 |
Industry average 2012 |
% |
|
|
Weeks |
52 |
|
52 |
|
52 |
|
|
|
|
Currency |
EUR |
|
EUR |
|
EUR |
|
|
|
|
Intangible fixed assets |
0 |
- |
0 |
- |
0 |
1,849,857 |
-100 |
|
|
Tangible fixed assets |
21,665 |
290 |
5,543 |
41.35 |
3,922 |
1,021,826 |
97.88 |
|
|
Land & building |
- |
- |
- |
- |
- |
923,797 |
- |
|
|
Plant & machinery |
152 |
33.33 |
228 |
25.00 |
304 |
391,507 |
-99 |
|
|
Furniture & Vehicles |
10,731 |
101 |
5,315 |
46.93 |
3,617 |
60,536 13,370 |
82.27 |
|
|
Leasing & Other
Similar Rights |
- |
- |
- |
- |
- |
699,547 17,295 |
- |
|
|
Other tangible assets |
10,782 |
- |
0 |
- |
0 |
172,874 |
93.76 |
|
|
Financial fixed assets |
14,599 |
-7.65 |
15,808 |
7.37 |
14,722 |
18,032,608 |
-99 |
|
|
Total fixed assets |
36,263 |
69.84 |
21,351 |
14.52 |
18,644 |
14,632,407 |
-99 |
|
|
Inventories |
498,226 |
46.27 |
340,612 |
112 |
160,654 |
3,247,117 |
84.66 |
|
|
Raw materials &
consumables |
- |
- |
- |
- |
- |
1,933,944 |
- |
|
|
Work in progress |
0 |
- |
0 |
- |
0 |
7,566 |
-100 |
|
|
Finished goods |
0 |
- |
0 |
- |
0 |
1,832,403 |
-100 |
|
|
Other stocks |
498,226 |
46.27 |
340,612 |
112 |
160,654 |
88,693 |
461 |
|
|
Trade debtors |
477,208 |
29.37 |
675,636 |
272 |
181,382 |
2,915,234 |
83.63 |
|
|
Cash |
275,112 |
411 |
53,825 |
52.23 |
112,678 |
495,643 |
44.49 |
|
|
other amounts receivable |
61,429 |
842 |
6,516 |
89.36 |
61,267 |
1,640,541 |
96.26 |
|
|
Miscellaneous current assets |
204 |
597 |
29 |
-99 |
5,297 |
353,786 |
-99 |
|
|
Total current assets |
1,312,179 |
21.88 |
1,076,619 |
106 |
521,278 |
7,368,450 |
82.19 |
|
|
Total Assets |
1,348,442 |
22.81 |
1,097,970 |
103 |
539,922 |
20,866,405 588,918 |
93.54 |
|
|
CURRENT LIABILITIES |
|||||||
|
|
Trade creditors |
1,438,960 |
32.32 |
1,087,450 |
147 |
439,453 |
2,647,405 |
45.65 |
|
|
Short term group loans |
- |
- |
- |
- |
- |
- |
- |
|
|
Financial debts |
- |
- |
- |
- |
- |
2,281,352 38,045 |
- |
|
|
Current portion of long term debt |
2,719 |
- |
- |
- |
- |
263,891 20,340 |
98.97 |
|
|
Amounts Payable for
Taxes, Remuneration & Social Security |
11,392 |
24.38 |
15,065 |
24.65 |
19,994 |
23,596 - |
97.48 |
|
Miscellaneous current liabilities |
0 |
-100 |
12,751 |
33.40 |
19,147 |
-100 |
- - |
|
|
|
Total current liabilities |
1,453,071 |
30.29 |
1,115,266 |
133 |
478,594 |
5,888,995 |
75.33 |
|
|
LONG TERM DEBTS AND LIABILITIES |
|||||||
|
|
Long term group loans |
- |
- |
- |
- |
- |
- |
- - |
|
|
Other long term loans |
853,013 |
-8.65 |
933,828 |
-0.92 |
942,498 |
-92.35 |
- - |
|
|
Deffered taxes |
- |
- |
- |
- |
- |
130,387 23,096 |
- |
|
|
Provisions for Liabilities & Charges |
0 |
- |
0 |
- |
0 |
279,005 0 |
-100 |
|
|
Other long term liabilities |
0 |
- |
0 |
- |
0 |
98,346 |
-100 |
|
|
Total long term debts |
853,013 |
-8.65 |
933,828 |
-0.92 |
942,498 |
5,476,091 |
84.42 |
|
|
SHAREHOLDERS EQUITY |
|||||||
|
|
Issued share capital |
332,772 |
0 |
332,772 |
0 |
332,772 |
7,051,437 |
95.28 |
|
|
Share premium account |
- |
- |
- |
- |
- |
15,915,742 |
- |
|
|
Reserves |
-1,290,414 |
-0.51 |
-1,283,896 |
-5.76 |
-1,213,943 |
1,667,139 |
-177 |
|
|
Revaluation reserve |
- |
- |
- |
- |
- |
938,993 |
- |
|
|
Total shareholders equity |
-957,642 |
-0.69 |
-951,124 |
-7.94 |
-881,171 |
9,435,604 |
-110 |
|
|
Working capital |
-140,892 |
-264 |
-38,647 |
-190 |
42,684 |
1,479,455 |
-109 |
|
|
Cashflow |
771 |
1.15 |
-66,965 |
-499 |
16,767 |
954,764 |
-99 |
|
|
Net worth |
-957,642 |
-0.69 |
-951,124 |
-7.94 |
-881,171 |
7,574,083 |
-112 |
ratio analysis
|
|
Annual accounts |
31-12-2012 |
change(%) |
31-12-2011 |
change(%) |
31-12-2010 |
Industry
average 2012 |
% |
|
|
TRADING PERFORMANCE |
|
|
|
|
|
|
|
|
|
Profit Before Tax |
- |
- |
- |
- |
- |
27,00 |
- |
|
|
Return on capital employed |
7.84 |
-98.32 |
465.48 |
3609 |
12.55 |
3,00 |
161 |
|
|
Return on total assets employed |
-0.61 |
8.32 |
-7.33 |
-612 |
1.43 |
-48,00 |
1.27 |
|
|
Return on net assets employed |
0.86 |
-89.83 |
8.46 |
972 |
-0.87 |
9,00 |
-90.44 |
|
|
Sales / net working capital |
- |
- |
- |
- |
- |
6,00 |
- |
|
|
Stock turnover ratio |
- |
- |
- |
- |
- |
17,00 |
- |
|
|
Debtor days |
- |
- |
- |
- |
- |
129,00 |
- |
|
|
Creditor days |
- |
- |
- |
- |
- |
86,00 |
- |
|
SHORT TERM STABILITY |
||||||||
|
|
Current ratio |
0.90 |
-7.22 |
0.97 |
-11.01 |
1.09 |
175,00 |
-55.00 |
|
|
Liquidity ratio / acid ratio |
0.56 |
-15.15 |
0.66 |
-12.00 |
0.75 |
175,00 |
-99 |
|
|
Current debt ratio |
-1.52 |
-29.91 |
-1.17 |
-116 |
-0.54 |
2,00 |
-176 |
|
|
Liquidity ratio reprocessed |
- |
- |
- |
- |
- |
- |
- |
|
|
LONG TERM STABILITY |
|||||||
|
|
Gearing |
-89.36 |
91.02 |
-98.18 |
91.79 |
-106.96 |
157,00 |
-156 |
|
|
Equity in percentage |
-71.02 |
81.98 |
-86.63 |
53.08 |
-163.20 |
-232,00 |
30.61 |
|
|
Total debt ratio |
-2.41 |
-12.09 |
-2.15 |
-33.54 |
-1.61 |
3,00 |
-180 |
|
Activity
code |
46460 |
|
Activity
description |
Wholesale of pharmaceutical goods |
|
industry average credit rating |
61.92 |
|
Industry
average credit limit |
125496.30 |
Payment Information Summary
Total number of Invoices available 1
Total number of Invoices paid within or up to
30 days after the due date 0
Total number of Invoices paid more than 30
days after the due date 0
Total number of Invoices currently
outstanding where the due date has not yet been reached 1
Total number of Invoices currently outstanding beyond the
due date 0
|
Amount |
- |
|
Details |
- |
|
Payment
expectations |
|
|
Payment
expectation days |
- |
|
Day
sales outstanding |
- |
|
Industry
comparison |
|
|
Activity
code |
46460 |
|
Activity
description |
Wholesale of pharmaceutical goods |
|
Industry average payment expectation days |
75.44 |
|
Industry average day sales outstanding |
115.08 |
|
Industry
quartile analysis |
|
|
Payment
expectations |
|
|
Company
result |
- |
|
Lower |
107.35 |
|
Median |
68.18 |
|
Upper |
39.50 |
|
Company
result |
- |
|
Lower |
89.27 |
|
Median |
49.37 |
|
Upper |
24.33 |
Summary
|
Group
- Number of Companies |
0 |
|
Linkages
- Number of Companies |
0 |
|
Number
of Countries |
0 |
No group structure for this company.
Minority Shareholders
|
Business
number |
Company
name |
|
Date of accounts |
|
- |
PHARE |
- |
- |
|
450625970 |
Wolfs
Pharmaceuticals p/a BTW_Ka NV |
20.6 |
31/07/2003 |
Minority
Interests
Individual Shareholders
|
SHAREHOLDER
NAME |
|||
|
Forename |
Patrick |
Middle
name |
Emmanuel |
|
Surname |
Swolfs |
|
|
|
SHAREHOLDER
DETAILS |
|||
|
Start
date |
25/04/1995 |
End
date |
- |
|
Percentage
owned |
- |
|
|
|
SHAREHOLDER
ADDRESS |
|||
|
Street
name |
Leliestraat |
House
number |
67 |
|
Minor
town |
- |
Postal
town |
Hove |
|
Post
code |
2540 |
Country |
Belgium |
|
|
|||
|
|
|||
|
SHAREHOLDER
NAME |
|||
|
Forename |
Frank |
Middle
name |
- |
|
Surname |
Peeters |
|
|
|
SHAREHOLDER
DETAILS |
|||
|
Start
date |
25/04/1995 |
End
date |
- |
|
Percentage
owned |
- |
|
|
|
SHAREHOLDER
ADDRESS |
|||
|
Street
name |
Den Heuvel |
House
number |
52 |
|
Minor
town |
- |
Postal
town |
Schilde |
|
Post
code |
2970 |
Country |
Belgium |
Companies that match this address
|
Business
number |
Company
name |
Rating |
Limit |
Date
of accounts |
|
843002254 |
GLOBIPHARM BVBA |
- |
- |
- |
|
843493885 |
GLOBIFER INTL BVBA |
- |
- |
- |
|
874870516 |
KINGFISHER HEALTHCARE NV |
- |
- |
31/12/2011 |
Linked Companies
Summary
|
Group
- Number of Companies |
0 |
|
Linkages
- Number of Companies |
0 |
|
Number
of Countries |
0 |
|
Protested
bills |
|
|
Drawee
name |
PHARMACEUTICAL ENTERPRISES BELGIUM NV |
|
Address |
MOLENBERGLEI 20, SCHELLE, 2627 |
|
Bill
amount |
36.712,12 |
|
Bill
currency |
EUR |
|
Maturity
of bill |
110 |
|
Name
of drawer |
CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE SA |
|
City
of drawer |
ANDERLECHT |
|
View more |
|
|
NSSO
details |
|
|
Business
number |
455014924 |
|
Name
of defendant |
PHARMACEUTICAL ENTERPRISES BELGIUM |
|
Legal
form of defendant |
Limited company |
|
Date
of summons |
06/03/2006 |
|
Labour
court |
ANTWERPEN |
|
View more |
|
Bankruptcy details
|
Bankruptcy
type |
compulsory composition, end of final suspension |
|
Company
name |
PHARMACEUTICAL ENTERPRISES BELGIUM NV |
|
Street
of registered office |
MOLENBERGLEI 20 |
|
Postcode
of registered office |
2627 |
|
City
of registered office |
SCHELLE |
|
Trade
name |
PHARE BELGIUM |
|
NACeBEL
code |
51460 |
|
NACeBEL
description |
Wholesale of pharmaceutical goods |
|
Commercial
court |
ANTWERPEN |
|
Source
date |
28/11/2007 |
|
Source |
Moniteur Belge (MB) |
|
Judgement
date end of final suspension |
20/11/2007 |
Legal events
|
Legal
event type |
Social Security Summons |
||
|
Legal
event sub type |
|
||
|
Event
date |
29/03/2043 |
Secondary
event date |
|
|
Court
number |
|
Registry
body identfier |
|
|
Court
type |
Employment Court |
Court
name |
Antwerpen |
|
3rd
party name |
Rijksdienst voor Sociale Zekerheid |
3rd
party type |
Summoning Party |
|
3rd
party address |
|
||
|
|
|||
|
Legal
event type |
Social Security Summons |
||
|
Legal
event sub type |
|
||
|
Event
date |
14/01/2008 |
Secondary
event date |
|
|
Court
number |
|
Registry
body identfier |
|
|
Court
type |
Employment Court |
Court
name |
Antwerpen |
|
3rd
party name |
Rijksdienst voor Sociale Zekerheid |
3rd
party type |
Summoning Party |
|
3rd
party address |
|
||
|
|
|||
|
Legal
event type |
Social Security Summons |
||
|
Legal
event sub type |
|
||
|
Event
date |
03/12/2007 |
Secondary
event date |
|
|
Court
number |
|
Registry
body identfier |
|
|
Court
type |
Employment Court |
Court
name |
Antwerpen |
|
3rd party name 3rd party address |
Rijksdienst voor Sociale Zekerheid |
3rd
party type |
Summoning Party |
|
Legal event type |
Judicial Reorganization Plan: Rejected by Court |
|
|
Legal event sub type
|
Legal
event type |
Social Security Summons |
||
|
Legal
event sub type |
|
||
|
Event
date |
05/11/2007 |
Secondary
event date |
|
|
Court
number |
|
Registry
body identfier |
|
|
Court
type |
Employment Court |
Court
name |
Antwerpen |
|
3rd
party name |
Rijksdienst voor Sociale Zekerheid |
3rd
party type |
Summoning Party |
3rd party address
Legal event type Social
Security Summons
|
Legal event sub type |
|
||
|
Event date |
06/03/2006 |
Secondary event date |
|
|
Court number |
|
Registry body identfier |
|
|
Court type |
Employment
Court |
Court name |
Antwerpen |
|
3rd party name |
Rijksdienst
voor Sociale Zekerheid |
3rd party type |
Summoning
Party |
|
3rd party address |
|
||
Director details
|
Current
director details |
|
|
Name |
PATRICK MARIE EMMANUEL SWOLFS |
|
Position |
Chairman of the Board |
|
Start
Date |
25/04/1995 |
|
Street |
67 LELIESTRAAT HOVE |
|
Post
code |
2540 |
|
Country |
Belgium |
|
|
|
|
Name |
PATRICK MARIE EMMANUEL SWOLFS |
|
Position |
Managing Director |
|
Start
Date |
25/04/1995 |
|
Street |
67 LELIESTRAAT HOVE |
|
Post
code |
2540 |
|
Country |
Belgium |
|
|
|
|
Name |
PATRICK MARIE EMMANUEL SWOLFS |
|
Position |
Director |
|
Start
Date |
03/10/2011 |
|
Street |
67 LELIESTRAAT HOVE |
|
Post
code |
2540 |
|
Country |
Belgium |
|
|
|
|
Name |
MARC JAN WAETERSCHOOT |
|
Position |
Director |
|
Start
Date |
29/06/2005 |
|
Date
of birth |
07/11/1949 |
|
Street |
51 HULSTLEI SCHELLE |
|
Post
code |
2627 |
|
Country |
Belgium |
|
|
|
|
Name |
MARC JAN WAETERSCHOOT |
|
Position |
Managing Director |
|
Start
Date |
09/09/2011 |
|
End
Date |
16/06/2017 |
|
Date
of birth |
07/11/1949 |
|
Street |
51 HULSTLEI SCHELLE |
|
Post
code |
2627 |
|
Country |
Belgium |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.38 |
|
UK Pound |
1 |
Rs.101.63 |
|
Euro |
1 |
Rs.83.57 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUB |
|
|
|
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors
are apparent. Repayment of interest and principal sums in default or expected
to be in default upon maturity |
Limited with full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.